Podcast: Celltrion’s Subcutaneous Infliximab And The Future Of Biosimilars
We Discuss The Celltrion Product Breaking New Ground For Biosimilars
• By David Wallace
David Wallace And Duncan Emerton Discuss Celltrion’s Subcutaneous Remsima • Source: Shutterstock